Extracorporeal magnetic approach to reduce the unwanted side-effects and improve antibacterial activity of Ag/Fe3 O4 nanocomposites in rat

J Biomed Mater Res B Appl Biomater. 2018 Jul;106(5):2029-2036. doi: 10.1002/jbm.b.33998. Epub 2017 Oct 27.

Abstract

While Ag nanoparticles hold great promise for broad spectrum antibacterial activity, the potential risks of Ag nanoparticles (NPs) on human health remain a challenge. In this study, Ag/Fe3 O4 composites have been successfully prepared and characterized by transmission electron microscopy, X-ray powder diffraction, and Fourier-transform infrared spectroscopy, and their magnetic and antibacterial properties have been assessed. In vivo results show that the antibacterial effect of 500 μg/mL Ag/Fe3 O4 nanocomposites was significantly higher than that of 1000 μg/mL AgNPs after 72 h of treatment (p < 0.01). Hematoxylin and eosin (HE) staining showed that squamous epithelium and dermis collagen fibers formed in the Ag/Fe3 O4 group after 8 days treatment. Wound closure was significantly better for the Ag/Fe3 O4 group than for the AgNPs group. On the other hand, there was less Ag in blood, liver, and kidney in the Ag/Fe3 O4 group, as more Ag was retained in the wound. According to lactate dehydrogenase, γ-glutamyl transpeptidase, and reactive oxygen species results, Ag/Fe3 O4 nanocomposites caused less unwanted side-effects. This work presents a new paradigm to reduce the unwanted side-effects of AgNPs and improve their antibacterial activity, providing a new avenue for wound healing. © 2017 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 106B: 2029-2036, 2018.

Keywords: Ag/Fe3O4; antibacterial activity; biosafety; wound healing.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anti-Bacterial Agents* / chemistry
  • Anti-Bacterial Agents* / pharmacology
  • Ferrosoferric Oxide* / chemistry
  • Ferrosoferric Oxide* / pharmacology
  • Male
  • Microscopy, Electron, Transmission
  • Molybdoferredoxin
  • Nanocomposites / adverse effects
  • Nanocomposites / chemistry*
  • Nanocomposites / ultrastructure
  • Rats
  • Rats, Sprague-Dawley
  • Reactive Oxygen Species / metabolism*
  • Silver* / chemistry
  • Silver* / pharmacology
  • Wound Healing / drug effects
  • Wound Infection / drug therapy*
  • Wound Infection / pathology
  • X-Ray Diffraction

Substances

  • Anti-Bacterial Agents
  • Molybdoferredoxin
  • Reactive Oxygen Species
  • Silver
  • Ferrosoferric Oxide